What is the Cipla PE ratio today?
Cipla's PE ratio is 37.9 at the 29 October 2026 close (₹1,358.00 a share): a market capitalisation of ₹1,09,706 crore divided by consolidated net profit attributable to shareholders of ₹2,897 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit attributable to shareholders (₹3,879 crore) it is 28.3.
What is the Cipla PB ratio (price to book value)?
Cipla's price-to-book (PB) ratio is 3.10 at the 29 October 2026 close: a market capitalisation of ₹1,09,706 crore divided by shareholders' equity (book value) of ₹35,396 crore on 30 September 2026. That is a book value of ₹438.14 per share against a share price of ₹1,358.00.
What is the Cipla net worth?
Cipla's net worth — shareholders' equity in its consolidated balance sheet — was ₹35,396 crore on 30 September 2026, up 7.5% from ₹32,919 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,09,706 crore at the 29 October 2026 close.
What is the Cipla market cap?
Cipla's market capitalisation was ₹1,09,706 crore (₹1.10 lakh crore) at the 29 October 2026 close: 80.79 crore shares at ₹1,358.00 each.
What is the Cipla EPS?
Cipla's basic earnings per share (EPS) were ₹48.03 in FY26, against ₹65.29 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹35.87.
What is the Cipla dividend in 2026 and its record date?
In 2026, Cipla has declared one dividend: ₹13 with record date 5 June 2026.
Is Cipla debt free?
No. Cipla had borrowings of ₹267 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.01. Its cash and current investments were ₹8,238 crore, so it held net cash of ₹7,971 crore.
What is the Cipla debt to equity ratio?
Cipla's debt-to-equity ratio was 0.01 on 30 September 2026: borrowings of ₹267 crore against total equity of ₹35,522 crore. A year earlier, on 30 September 2025, it was 0.00.
What is the Cipla dividend yield?
Cipla's dividend yield is 0.96% at the 29 October 2026 close: dividends of ₹13 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹1,358.00. They were ₹13 on 5 June 2026.
What is the Cipla ROE and ROCE?
In FY26, Cipla's return on equity (ROE) was 11.8% and its return on capital employed (ROCE) was 13.9%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 18.2% and ROCE 20.3%.
What is the Cipla book value per share?
Cipla's book value per share was ₹438.14 on 30 September 2026: shareholders' equity of ₹35,396 crore divided by the 80.79 crore shares in issue, up 7.5% from ₹407.54 a year earlier. The share price at the 29 October 2026 close was ₹1,358.00.
What is the Cipla shareholding pattern?
On 30 September 2026, Cipla's shares were held by promoters 29.21%, foreign portfolio investors (FII/FPI) 20.25%, domestic institutions (DII) 34.94% (including mutual funds at 20.78%) and retail and other non-institutional investors 15.60%. Over the year, FII holding was down 4.30 percentage points from 24.55% and DII holding was up 4.69 percentage points from 30.25%.
What is the Cipla promoter holding?
Promoters held 29.21% of Cipla on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What is the Cipla free cash flow?
In FY26, Cipla generated ₹3,940 crore of cash from operations and spent ₹3,079 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹861 crore. In FY25 it was ₹3,457 crore.
When are the Cipla next results?
Cipla has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
What are the Cipla latest quarterly results?
Cipla's latest results are for Q2 FY27 (July–September 2026), filed on 27 October 2026: consolidated net profit attributable to shareholders ₹878 crore, down 35.1% from ₹1,351 crore in Q2 FY26; revenue from operations ₹7,404 crore, down 2.4% year on year.
What is the Cipla revenue and profit in FY26?
In FY26 (April 2025–March 2026), Cipla's consolidated net profit attributable to shareholders was ₹3,879 crore, down 26.4% from ₹5,273 crore in FY25, on revenue from operations of ₹28,163 crore (up 2.2%). Over three years, from FY23, net profit was up 38.4%.
How does the Cipla PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Cipla's PE ratio is 28.3, the second highest of the four: Sun Pharma 36.8, Dr Reddy's 26.8 and Lupin 17.1, a peer average of 26.9. Each is the company's market capitalisation at that price divided by its FY26 net profit.
How does Cipla compare with its peers?
On FY26 consolidated figures, against Sun Pharma, Dr Reddy's and Lupin: Cipla's operating margin of 16.6% is the third highest of the four (Sun Pharma 25.3%, Dr Reddy's 13.0%, Lupin 26.6%; peer average 21.7%); its return on equity of 11.8% is the third highest of the four (Sun Pharma 14.7%, Dr Reddy's 11.8%, Lupin 26.9%; peer average 17.8%); its revenue growth over three years of 7.4% a year is the lowest of the four (Sun Pharma 10.0% a year, Dr Reddy's 11.0% a year, Lupin 18.9% a year; peer average 13.3% a year).
Cipla vs Sun Pharma: how do they compare?
In FY26, Cipla earned net profit attributable to shareholders of ₹3,879 crore on revenue of ₹28,163 crore, against ₹11,479 crore on ₹58,462 crore for Sun Pharma. Cipla's operating margin was 16.6% (Sun Pharma 25.3%) and its return on equity 11.8% (Sun Pharma 14.7%). At the 29 October 2026 close, Cipla's market capitalisation was ₹1,09,706 crore against ₹4,22,517 crore for Sun Pharma, and its PE ratio on FY26 profit 28.3 against 36.8.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
